Vonoprazan is Not Inferior to Proton Pump Inhibitors in Bismuth-containing Quadruple Therapy for Helicobacter pylori Eradication: A Meta-analysis of 10 Studies From East Asia.

IF 2.8 4区医学 Q2 GASTROENTEROLOGY & HEPATOLOGY

Journal of clinical gastroenterology Pub Date : 2024-04-12 DOI:10.1097/mcg.0000000000002001

Yujie Cheng, Lin Yang, Si Xu, Chong Zhang

引用次数: 0

Abstract

To investigate the efficacy and safety of vonoprazan based bismuth-containing quadruple therapy (VBCQ) in eradicating Helicobacter pylori (Hp).

查看原文本刊更多论文

在根除幽门螺旋杆菌的含铋四联疗法中，沃诺普拉赞的疗效并不优于质子泵抑制剂：东亚 10 项研究的 Meta 分析。

研究基于冯诺普拉赞的含铋四联疗法（VBCQ）在根除幽门螺杆菌（Hp）方面的有效性和安全性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of clinical gastroenterology 医学-胃肠肝病学

CiteScore

5.60

自引率

3.40%

发文量

339

审稿时长

3-8 weeks

期刊介绍： Journal of Clinical Gastroenterology gathers the world''s latest, most relevant clinical studies and reviews, case reports, and technical expertise in a single source. Regular features include cutting-edge, peer-reviewed articles and clinical reviews that put the latest research and development into the context of your practice. Also included are biographies, focused organ reviews, practice management, and therapeutic recommendations.

文献相关原料

公司名称	产品信息	采购帮参考价格